[(9-ethyl-9H-carbazol-3-ylamino)-phosphono-methyl]-phosphonic acid

ID: ALA200262

PubChem CID: 5277469

Max Phase: Preclinical

Molecular Formula: C15H18N2O6P2

Molecular Weight: 384.27

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCn1c2ccccc2c2cc(NC(P(=O)(O)O)P(=O)(O)O)ccc21

Standard InChI:  InChI=1S/C15H18N2O6P2/c1-2-17-13-6-4-3-5-11(13)12-9-10(7-8-14(12)17)16-15(24(18,19)20)25(21,22)23/h3-9,15-16H,2H2,1H3,(H2,18,19,20)(H2,21,22,23)

Standard InChI Key:  FOIJEVZWWJSXFM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    4.4074    0.0390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1243    0.4527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1215    1.2838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4056    1.6933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8350    1.6993    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5515    1.2892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2650    1.7047    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    6.5546    0.4636    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    6.5468   -0.3586    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3803    0.4612    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7290    0.4626    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9771    2.1225    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6816    0.9920    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8485    2.4176    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6920    0.4522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6932    1.2772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9070    0.1985    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4230    0.8666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9080    1.5303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5755    2.2800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7584    2.3672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2748    1.6986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6100    0.9515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6507   -0.5864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2022   -1.2007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  7 12  2  0
 15  1  1  0
  7 13  1  0
  5  6  1  0
  7 14  1  0
 15 16  2  0
  2  3  1  0
  6  7  1  0
 16 19  1  0
 18 17  1  0
 17 15  1  0
  6  8  1  0
  3  4  2  0
 18 19  2  0
  8  9  2  0
 19 20  1  0
  4 16  1  0
 20 21  2  0
  8 10  1  0
 21 22  1  0
  1  2  2  0
 22 23  2  0
 23 18  1  0
  8 11  1  0
 17 24  1  0
  3  5  1  0
 24 25  1  0
M  END

Associated Targets(Human)

KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

HK Hexokinase (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dictyostelium discoideum (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Farnesyl pyrophosphate synthase (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 384.27Molecular Weight (Monoisotopic): 384.0640AlogP: 2.87#Rotatable Bonds: 5
Polar Surface Area: 132.02Molecular Species: ACIDHBA: 4HBD: 5
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 0.95CX Basic pKa: CX LogP: 1.86CX LogD: -2.96
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.43Np Likeness Score: -0.71

References

1. Hudock MP, Sanz-Rodríguez CE, Song Y, Chan JM, Zhang Y, Odeh S, Kosztowski T, Leon-Rossell A, Concepción JL, Yardley V, Croft SL, Urbina JA, Oldfield E..  (2006)  Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates.,  49  (1): [PMID:16392806] [10.1021/jm0582625]
2. Leon A, Liu L, Yang Y, Hudock MP, Hall P, Yin F, Studer D, Puan KJ, Morita CT, Oldfield E..  (2006)  Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.,  49  (25): [PMID:17149863] [10.1021/jm060492b]
3. Sanz-Rodríguez CE, Concepción JL, Pekerar S, Oldfield E, Urbina JA..  (2007)  Bisphosphonates as inhibitors of Trypanosoma cruzi hexokinase: kinetic and metabolic studies.,  282  (17): [PMID:17329254] [10.1074/jbc.m607286200]
4. Vermelho AB, Capaci GR, Rodrigues IA, Cardoso VS, Mazotto AM, Supuran CT..  (2017)  Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets.,  25  (5): [PMID:28161253] [10.1016/j.bmc.2017.01.034]

Source